Quest Diagnostics, Keysight Technologies And A Stock Up 42% Year To Date On CNBC's 'Final Trades'
Portfolio Pulse from Lisa Levin
On CNBC's 'Halftime Report Final Trades', Jason Snipe of Odyssey Capital Advisors recommended Quest Diagnostics (DGX), Stephanie Link of Hightower recommended Keysight Technologies (KEYS), and Joshua Brown of Ritholtz Wealth Management recommended Live Nation Entertainment (LYV). DGX recently launched a novel prostate cancer test, KEYS announced its intention to acquire ESI Group SA, and LYV bought a majority interest in Páramo Presenta in Colombia.
July 19, 2023 | 12:58 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Quest Diagnostics was recommended by Jason Snipe and recently launched a novel prostate cancer test.
The recommendation by a respected analyst and the launch of a new product could positively impact the stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Keysight Technologies was recommended by Stephanie Link and recently announced its intention to acquire ESI Group SA.
The recommendation by a respected analyst and the announcement of a significant acquisition could positively impact the stock in the short term.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100
POSITIVE IMPACT
Live Nation Entertainment was recommended by Joshua Brown and recently bought a majority interest in Páramo Presenta in Colombia.
The recommendation by a respected analyst and the acquisition of a majority interest in a company could positively impact the stock in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100